VACCINES PROCUREMENT SERVICES SECOND QUARTER 2026

Đã hết hạn nhận báo giá

Find: 10:52 16/04/2026

Bid info

Project name/purchase estimate

VACCINES PROCUREMENT SERVICES SECOND QUARTER 2026

Bid name

VACCINES PROCUREMENT SERVICES SECOND QUARTER 2026

Basic information of the request for quotation

Request for quotation code

RQ2600013429-00

Status

Posted

Name of request for quotation

VACCINES PROCUREMENT SERVICES SECOND QUARTER 2026

Unit requesting quote

TRẠM Y TẾ PHƯỜNG PHÚ LÂM

Address of the unit requesting a quote

No. A14/1 Ba Hom, Phường Phú Lâm, City Hồ Chí Minh

Categorize quotation requests

Bidding package for purchasing medicine

Contact information of the person responsible for receiving the quotation

Full Name

NGÔ TỐ TRÂN

Position

Staff

Phone number

0908746521

Address

A14/1 BA HOM, PHU LAM WARD, HCMC (ACCOUNTING DEPARTMENT)

[email protected]

How to receive quotation

Form of receiving quotation

Offline Email

Location of request for quotation

http://muasamcong.mpi.gov.vn

Quotation acceptance time

Since 16/04/2026 10:49 To date 29/04/2026 17:00

Validity period of quotation

90 Day kể từ ngày 29/04/2026 17:00

Request for quotation

Content of request for quotation

Filter data

Show: data/page

No	Medicine code	Active ingredient name	Technical criteria group	Concentration or content	How to use	Dosage form	Unit	Quantity
1	GCFLU Quadrivalent Pre-Filled Syringe Inj.	Influenic antigen of strains	Group 2	15mcg HA/strain/0.5ml/dose	Inject	Injection	Dose	30
2	Influvac Tetra	Seasonal flu vaccine (4 strains)	Group 1	0.5ml/dose	Inject	Injection	Dose	30
3	Vaxigrip Tetra	Seasonal flu vaccine (4 strains)	Group 1	0.5ml/dose	Inject	Injection	Dose	20
4	Indirab	Inactivated rabies virus (Pitman Moore strain) propagated on Vero cells	Group 5	> = 2.5UI/0.5ml	Inject	Injection	Dose	200
5	Abhayrab	Inactive rabies virus (L. Pasteur 2061/Vero is propagated on Vero cells) ≥ 2.5 IU	Group 5	> = 2.5UI/0.5ml	Inject	Injection	Dose	200
6	Verorab rabies (inactivated), prepared on cell culture soup	Inactive virus (Wistar PM/Wi 30 1503-3M)	Group 1	≥ 2.5iu /0.5 ml	Inject	Injection	Dose	300
7	Priorix	Live virus vaccine to prevent measles, mumps, and rubella	Group 1	≥ 10^3.0 ccID50; ≥ 10^3.7 ccID50; ≥ 10^3.0 ccID50	Inject	Injection	Dose	20
8	Measles, Mumps and Rubella Vaccine Live, attenuated (Freeze-Dried)	Live virus vaccine to prevent measles, mumps, and rubella	Group 5	0.5 ml/dose	Inject	Injection	Dose	20
9	Infanrix Hexa	Combining 6 -disease vaccine: diphtheria - pertussis - tetanus - polio - hib and hepatitis B	Group 1	0.5ml/dose	Inject	Injection	Dose	10
10	Tetraxim	Combining 4 -disease vaccine: Diphtheria - Perfect - Tetanese - Licensing	Group 1	0.5ml/dose	Inject	Injection	Dose	10
11	Adacel	Vaccination vaccine in diphtheria - Perfect - tetanus	Group 5	0.5ml/dose	Inject	Injection	Dose	5
12	Prevenar 20	Vaccine to prevent pneumonia and systemic infections caused by pneumococcal Streptococcus Each single dose of 0.5 ml: Pneumococcal polysaccharide type 1 serum 2.2 mcg; Pneumococcal polysaccharide type 3 serum 2.2 mcg; Pneumococcal polysaccharide type 4 serum 2.2 mcg; Pneumococcal polysaccharide type 5 serum 2.2 mcg; Serum type 6A pneumococcal polysaccharide 2.2 mcg; Serum type 6B pneumococcal polysaccharide 4.4 mcg; Pneumococcal polysaccharide type 7F serum 2.2 mcg; Pneumococcal polysaccharide type 8 serum 2.2 mcg; Serum type 9V pneumococcal polysaccharide 2.2 mcg; Serum type 10A pneumococcal polysaccharide 2.2 mcg; Serum type 11A pneumococcal polysaccharide 2.2 mcg; Serum type 12F pneumococcal polysaccharide 2.2 mcg; Pneumococcal polysaccharide type 14 serum 2.2 mcg; Serum type 15B pneumococcal polysaccharide 2.2 mcg; Serum type 18C pneumococcal polysaccharide 2.2 mcg; Serum type 19A pneumococcal polysaccharide 2.2 mcg; Serum type 19F pneumococcal polysaccharide 2.2 mcg; Serum type 22F pneumococcal polysaccharide 2.2 mcg; Serum type 23F pneumococcal polysaccharide 2.2 mcg; Serum type 33F pneumococcal polysaccharide 2.2 mcg; (20 pneumococcal-saccharide conjugates with CRM197)	Group 1	0.5ml/dose.	Inject	Injection	Dose	20
13	Synflorix	Polysaccharide vaccine is associated with protein D of Haemophilus Influenzae without tube	Group 1	1mcg 3mcg	Inject	Injection	Dose	5
14	Menquadfi	Each dose of 0.5ml contains: polysaccharide brain meningococcal (serum a) (unit price plus)* 10mcg; Mocca brain polysaccharide (serum C) (unit price plus)10mcg; Mocca polysaccharide (Serum group W135) (Collective unit price) 10mcg; Polysaccharide brain meningococcal (serum medical group) (unit price plus) * 10mcg * is added to the carrier is a tetanus detoxification protein about 55mcg	Group 1;5	Each dose of 0.5ml contains: polysaccharide brain meningococcal (serum a) (unit price plus)* 10mcg; Mocca brain polysaccharide (serum C) (unit price plus)10mcg; Mocca polysaccharide (Serum group W135) (Collective unit price) 10mcg; Polysaccharide brain meningococcal (serum medical group) (unit price plus) * 10mcg * is added to the carrier is a tetanus detoxification protein about 55mcg	Inject	Injection	Dose	5
15	Bexsero	Each dose (0.5 ml) contains: - Synthetic protein (fusion protein) NHBA NHBA NHBA Neisseria Meningitidis Group B recombinant: 50mcg. - Nada Nada Nada Nada Nada Nada Meningitidis group B recombinant: 50mcg. -Protein synthesized FHBP Neisseria meningitidis group B recombinant: 50mcg. - The external membrane bag from Neisseria meningitidis group B strain NZ98/254 is measured by the total amount of protein containing Pora P1.4: 25mcg	Group 1	Each dose (0.5 ml) contains: - Synthetic protein (fusion protein) NHBA NHBA NHBA Neisseria Meningitidis Group B recombinant: 50mcg. - Nada Nada Nada Nada Nada Nada Meningitidis group B recombinant: 50mcg. -Protein synthesized FHBP Neisseria meningitidis group B recombinant: 50mcg. - The external membrane bag from Neisseria meningitidis group B strain NZ98/254 is measured by the total amount of protein containing Pora P1.4: 25mcg	Inject	Injection	Dose	5
16	VA-MOCTH-BC	Causing brain room vaccine (group B; Group C)	Group 5	Each dose of 0.5ml contains: Membrane meningococcal protein group B 50µg; Polysaccharide cerebral cerebral cerebral tissue group C 50µg	Inject	Injection	Dose	30
17	Varilrix	Chickenpox vaccine	Group 1,2,5	≥ 103.3 pfu	Inject	Injection	Dose	30
18	Gardasil 9	Cervical Cancer Prevention Vaccine (9 strains)	Group 1	0.5 ml/dose	Inject	Injection	Dose	10
19	Twinrix	Hepatitis A and B vaccine	Group 1	0.5 ml/dose	Inject	Injection	Dose	10
20	Hepatitis B vaccine recombinant gene-hbvax	Hepatitis B vaccine	Group 4	20mcg/1ml/dose	Inject	Injection	Dose	20
21	Imojev	Japanese encephalitis vaccine	Group 5	Each dose of 0.5ml of revert vaccine contains: Japanese encephalitis virus SA14-14-2, recombinant, living, reducing poison 4.0-5.8 log pfu	Inject	Injection	Dose	20
22	Shingrix	Each dose of 0.5ml after reconciliation contains 50mcg antigens GE recombinant of the Varicella Zoster virus (VZV) is supplemented with AS01B	Group 1	Each dose of 0.5ml after reconciliation contains 50mcg antigens GE recombinant of the Varicella Zoster virus (VZV) is supplemented with AS01B	Inject	Injection	Dose	5
23	Qdenga	Each vaccine 0.5ml after reconciliation contains: serum type 1 virus dengue (dengue fever) (living, reducing toxicity) ≥ 3.3 log 10 pfu; Serum tube 2 virus dengue (dengue virus) (living, reducing poison) ≥ 2.7 log 10 pfu; Serum tube 3 virus dengue (dengue virus) (living, reducing poison) ≥ 4.0 log 10 pfu; Serum tube 4 Virus Dengue (Dengue Virus) (Living, reducing poison) ≥ 4.5 log 10 pfu	Group 1.5	Each vaccine 0.5ml after reconciliation contains: serum type 1 virus dengue (dengue fever) (living, reducing toxicity) ≥ 3.3 log 10 pfu; Serum tube 2 virus dengue (dengue virus) (living, reducing poison) ≥ 2.7 log 10 pfu; Serum tube 3 virus dengue (dengue virus) (living, reducing poison) ≥ 4.0 log 10 pfu; Serum tube 4 Virus Dengue (Dengue Virus) (Living, reducing poison) ≥ 4.5 log 10 pfu	Inject	Injection	Dose	5
24	Hexaxim	Each dose of 0.5ml contains: Diphore detoxification: No less than 20 IU; Tetanintic detoxification: No less than 40 IU; Bordetella pertussis antigen: Detoxifying pertussis (PT): 25mcg, fiber red blood cells (FHA): 25mcg; Polio virus (inactivated): Type 1 (Mahoney): 40 units of antigen D, type 2 (MEF-1) 8 units of antigen D, type 3 (afterket) 32 units of antigen D; Hepatitis B surface antigen: 10mcg; Polysaccharide of Haemophilus Influenzae B (Polyribosylribitol Phosphate): 12mcg plus tetanus protein 22-36 mcg	Group 1	0.5ml/ dose	Inject	Injection	Dose	10
25	Adsorbed tetanus vaccine (TT)	Detoxification refined tetanus ≥ 40 IU/0.5ml	Group 4	0.5ml/ dose	Inject	Injection	Dose	100
26	Pure, inactivated hepatitis A vaccine	Each 0.5ml dose contains protein including pure hepatitis A virus antigen <100µg; Each dose of 1ml containing protein includes pure hepatitis A virus antigen <200µg	Group 4	Each 0.5ml dose contains protein including pure hepatitis A virus antigen <100µg; Each dose of 1ml containing protein includes pure hepatitis A virus antigen <200µg	Inject	Injection	Dose	10

Approval decision information

Approval date

15/04/2026

Approval decision code

245/TB-TYT

Approval decision file

Downloading files directly on the new Public Procurement System requires a computer using Windows operating system and installing Client Agent software (Linux and MacOS operating systems cannot install Client software yet). Therefore, to be able to download files on smartphones, tablets or computers using operating systems other than Windows, you need to use DauThau.info software to download files.
To download, please Login or Register

Thông báo mời báo giá việc mua sắm vắc xin dịch vụ Q2 2026_2.pdf

Files with this icon are not supported by the public procurement system for direct download in normal mode. Visit DauThau.info and select Quick Download mode to download the file if you do not use Windows with Agent. DauThau.info supports downloading on most modern browsers and devices!
In case it is discovered that the BMT does not fully attach the E-HSMT file and design documents, the contractor is requested to immediately notify the Investor or the Authorized Person at the address specified in Chapter II-Data Table in E- Application form and report to the Procurement News hotline: 02437.686.611

Utilities for you

Follow quote requests

The Track Request for Quotation function helps you quickly and promptly receive email notifications of changes to Request for Quotation "VACCINES PROCUREMENT SERVICES SECOND QUARTER 2026". Our software will track the requests for quotations that you have registered for you. When there is any change, it will immediately send you an email notification.

Receive similar quote requests via email

To be one of the first to receive similar Requests for Quotations by email: "VACCINES PROCUREMENT SERVICES SECOND QUARTER 2026" as soon as they are published, subscribe to DauThau.info's VIP 8 package.

You did not use the site, Click here to remain logged. Timeout: 60 second